Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.

Clark, A J; Ahmedzai, S H; Allan, L G; Camacho, F; Horbay, G L A; Richarz, U; Simpson, K

Clark, A J; Ahmedzai, S H; Allan, L G; Camacho, F; Horbay, G L A; Richarz, U; Simpson, K.

Affiliation

Clark AJ; Pain Management Unit, Dalhousie University, Halifax, NS, Canada. john.clark@cdha.nshealth.ca

Curr Med Res Opin ; 20(9): 1419-28, 2004 Sep.

Article in En | MEDLINE | ID: mdl-15383190

Subject(s)

Analgesics, Opioid/administration & dosage; Fentanyl/administration & dosage; Morphine/administration & dosage; Neoplasms/complications; Pain/drug therapy; Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid/adverse effects; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fentanyl/adverse effects; Humans; Male; Middle Aged; Morphine/adverse effects; Pain/etiology; Randomized Controlled Trials as Topic

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pain / Fentanyl / Analgesics, Opioid / Morphine / Neoplasms Type of study: Clinical_trials / Etiology_studies / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 2004 Document type: Article

Search on Google

XML

PubMed Links